Prior exposure of thyroid slices to thyrotropin (TSH) induced refractoriness to subsequent stimulation of the cyclic AMP system by the hormone. Although the inhibition is incomplete, we examined whether the reduction in cyclic AMP was sufficient to alter other metabolic effects of TSH. Bovine or dog thyroid slices were incubated with or without 5-100 mU/ml TSH for 1-2h, washed, and then incubated without hormone for 1-2h. Half of the slices not exposed to TSH initially were then incubated with buffer and half were exposed to 5-100 mU/ml TSH. Slices initially incubated with TSH were also incubated with or without TSH in the third incubation. During the refractory period, TSH activation of protein kinase was inhibited even though the hormone still caused some increase in cyclic AMP concentrations. However, protein kinase activity was fully responsive to dibutyryl cyclic AMP when slices were incubated with it during the third incubation. Stimulation of glucose oxidation by TSH was significantly decreased in thyroid slices previously incubated with the hormone. During refractoriness, stimulation of glucose oxidation caused by prostaglandin E1 and dibutyryl cyclic AMP was also significantly diminished but that due to acetylcholine was not. Thus even though dibutyryl cyclic AMP could fully activate protein kinase activity during refractoriness, its effect on glucose oxidation was still inhibited, suggesting that the metabolic block responsible for this […] A B S T R A C T Prior exposure ofthyroid slices to thyrotropin (TSH) induced refractoriness to subsequent stimulation of the cyclic AMP system by the hormone. Although the inhibition is incomplete, we examined whether the reduction in cyclic AMP was sufficient to alter other metabolic effects of TSH. Bovine or dog thyroid slices were incubated with or without 5-100 mU/ml TSH for 1-2h, washed, and then incubated without hormone for 1-2 h. Half of the slices not exposed to TSH initially were then incubated with buffer and half were exposed to 5-100 mU/ml TSH. Slices initially incubated with TSH were also incubated with or without TSH in the third incubation. During the refractory period, TSH activation of protein kinase was inhibited even though the hormone still caused some increase in cyclic AMP concentrations. However, protein kinase activity was fully responsive to dibutyryl cyclic AMP when slices were incubated with it during the third incubation. Stimulation of glucose oxidation by TSH was significantly decreased in thyroid slices previously incubated with the hormone. During refractoriness, stimulation of glucose oxidation caused by prostaglandin E1 and dibutyryl cyclic AMP was also significantly diminished but that due to acetylcholine was not. Thus even though dibutyryl cyclic AMP could fully activate protein kinase activity during refractoriness, its effect on glucose oxidation was still inhibited, suggesting that the metabolic block responsible for this refractoriness was distal to activation of protein kinase. Stimulation of 32P, incorporation into phospholipid by TSH and acetylcholine was Received for publication 23 August 1976 and in revised form 29 November 1976. also inhibited during refractoriness. Despite reduction of the stimulatory effect of TSH, binding of 125I1 TSH was not modified by prior incubation of thyroid slices with TSH. These results indicate that changes in the TSH receptor are not responsible for the development of refractoriness and other metabolic sites besides activation of adenylate cyclase appear to be involved.
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INTRODUCTION
We previously reported that the cyclic 3', 5'-adenosine monophosphate (cyclic AMP) response to thyrotropin (TSH)1 was significantly reduced in thyroid slices previously exposed to the hormone (1) Beef thyroid slices weighing between 60 and 90 mg were incubated with and without 5 mU/ml TSH during the first incubation for 2 h. The second incubation in buffer alone was also for 2 h. The third incubation was for 20 min in the presence of buffer, 5 mU/ml TSH or 12.5 or 125 ag/ml DBC as indicated. Theophylline was not present during the third incubation. Slices were homogenized at the end of the third incubation in 0.05 M sodium glycerophosphate buffer (pH, 6.5) containing 10 mM MgCI2, 10 mM NaF, 2 mM theophylline and 0.3 mM EGTA. The homogenate was centrifuged at 12,000 g for 15 min and the supemate was used for protein kinase assay. The protein kinase activity was measured with and without 1 AM cyclic AMP for 5 min with 100 j.g histone as substrate. Other slices were extracted in hot 50 mM sodium acetate buffer (pH, 4.0) at the end of the third incubation for measurement of cyclic AMP. The cyclic AMP concentration in slices never exposed to TSH was 186±24 pmol/g compared to 980±96 pmol/g in slices exposed to 5 mU/ml TSH only during the third incubation. The cyclic AMP concentration in slices exposed to 5 mU/ml TSH in only the first incubation was 252±32 pmol!g and was significantly (P < 0.01) increased to 658±17 in slices exposed to TSH during both the first and third incubations. The last value is significantly less (P < 0. (7) . After the initial incubation, slices were rinsed in excess 0.85% saline and then incubated for 1-2 h in 2 ml Krebs-Ringer bicarbonate buffer containing 1 mg/ml glucose. Slices were then rinsed in 0.85% saline, blotted on filter paper, and weighed. After this, some of the slices, both from the control and TSH group, were homogenized in 0.001 M Na bicarbonate buffer for determination of binding of 125I-TSH as described subsequently. The remainder of the slices were transferred to fresh buffer containing 1 mg/ml glucose and 1 mg/ml albumin and incubated for a third incubation of 20 min when cyclic AMP was measured. Of the control slices incubated in buffer without TSH in the first incubation, half were again incubated in buffer without TSH, and the other half were exposed to TSH for the first time. Similarly, of the slices incubated with TSH during the initial incubation, half were now incubated without TSH and the other half were re-exposed to the hormone. When glucose oxidation was measured, [1-_4C]glucose was added to the buffer during the third incubation, and the TSH concentration was 5 mU/ml. Incubation was for 45 min and 54CO2 production was determined as previously described (8) . The effect of dibutyryl cyclic AMP (DBC), prostaglandin El (PGE,) and acetylcholine (ACH) on glucose oxidation in thyroid slices refractory to TSH was assessed by adding these substances during the third incubation to slices which had been incubated with and without TSH during the first incubation. When 32pj incorporation into phospholipid was measured 10 J,Ci/ml Na 32P04 was added during the third incubation of 2h.
Incorporation of 32P, into phospholipids was determined as previously described (9) . Acetylcholine was added during the third incubation to some slices which had been incubated with and without TSH during the initial incubation. When acetylcholine was used, 0.4 mM eserine was also present in the buffer. Effects of TSH and DBC on activation of protein kinase
were assessed during the third incubation (20 min) by adding the substance to appropriate thyroid slices which had been incubated with and without TSH during the first incubation. After the third incubation, slices were homogenized and assayed for protein kinase activity in the presence and absence of 1 ,uM cyclic AMP (10) and for cyclic AMP (11) . Theophylline was not present during the third incubation.
Binding of 1251-TSH to homogenates obtained from thyroid slices after the second incubation was measured by the method of Kotani et al. (12) using microcentrifugation to separate the bound and free hormone. The homogenate was prepared by the method of Manley et al. (13) . The results are corrected for nonspecific binding which was measured in the presence of 100 mU/ml TSH and was less than 20% of the total binding. Under the conditions of the experiment, no loss of TSH or its receptors was apparent (12 (12) .
RESULTS
The data in Table I demonstrate that prior incubation of thyroid slices with TSH inhibits the subsequent ability of the hormone to activate protein kinase activity. The enzyme activity assayed without cyclic AMP was 2.4±0.3 pmol 32p; incorporated/mg of tissue per 5 min in slices never exposed to TSH and 3.2±0.2 in slices incubated with TSH only during the third incubation. The total enzyme activity (assayed with 1 ,uM cyclic AMP) was 5.7 pmol 32P, incorporated/mg of tissue per 5 min whether or not TSH was present during the third incubation. In slices not exposed to TSH in the first incubation, the protein kinase activity ratio (-cyclic AMP/+cyclic AMP) was significantly increased (P < 0.01) from 0.42±0.01 to 0.56±0.01 by the addition of TSH during the third incubation. The lack of a greater increase in the activity ratio can be attributed to the relatively modest increase in the cyclic AMP concentration (basal, 186±24 pmol/g; TSH, 980+96 pmol/g) induced by TSH in the absence of theophylline (10) . In contrast, 125 ,ug/ml DBC almost completely activated protein kinase (activity ratio 0.85±0.05). The smaller amount of DBC (12.5 ,ug/ml) induced less activation of protein kinase. In more extensive experiments (data not shown) this smaller amount of DBC was demonstrated to be less than maximal. The protein kinase activity of slices incubated with TSH during the first incubation only was decreased whether the assay was done with or without 1 ,uM cyclic AMP (1.6±0.1 and 3.&±0.2, respectively). Despite such reduction, the protein kinase activity ratio (0.43±0.04) was the same as in slices which had never been incubated with TSH. The addition of TSH to slices which had been incubated with the hormone in the first incubation did not augment protein kinase activity and the activity ratio was 0.45±0.02, significantly less (P < 0.02) than the value of 0.56±0.01 obtained in slices exposed to TSH only in the third incubation. Although the protein kinase was unresponsive to readdition of TSH x 106 cpm Na32PO4 was added and the Pi concentration was 0.0012 M. The total incubation volume was 2 ml. Test substances were present as indicated. The results are the mean±SEM of triplicate slices. (*)P < 0.01 when compared to slices which had never been exposed to TSH. (**)P < 0.01 when compared to slices which had been initially incubated with TSH. (f)P < 0.01 when compared to its appropriate control which had never been exposed to TSH.
tion; however this was not a constant finding. 5 mU/ml TSH added during the third incubation significantly (P < 0.01) stimulated glucose oxidation in slices which had not previously been exposed to the hormone. In contrast, no such stimulation was observed when the slices had also been incubated with TSH during the first incubation. During refractoriness induced by TSH, addition of 10 gg/ml PGE1 in the third incubation did not increase glucose oxidation. In contrast, PGEl significantly stimulated glucose oxidation in slices which had not previously been incubated with TSH. The stimulatory effect of 250 ,ug/ml DBC was also significantly inhibited when it was added to thyroid slices which had been incubated with TSH during the first incubation. Stimulation of glucose oxidation in dog thyroid slices by l,uM acetylcholine (14) was not altered by incubating slices with TSH during the first incubation. The results in Fig. 2 indicate that stimulation by TSH of 32p; incorporation into phospholipids is also significantly (P < 0.01) diminished during the refractory period induced by prior exposure of tissue to the hormone. 100 mU/ml TSH added during the third incubation doubled 32P, incorporation into phospholipid in dog thyroid slices not previously exposed to the hormone. However, the effect of TSH was significantly diminished when it was added to slices exposed to the hormone during the first incubation. In contrast to the results obtained when glucose oxidation was measured, the stimulatory effect of acetylcholine on 32p; incorporation into phospholipids (9) was decreased in thyroid slices exposed to TSH during the first incubation.
Our previous finding that TSH, but not NaF, stimulation of adenylate cyclase was decreased in tissue previously incubated with the hormone (1), suggested that refractoriness might reflect an alteration in either TSH binding to its receptors or in the transmission of the signal to the catalytic unit of adenylate cyclase. The data in Fig. 3 demonstrate that prior incubation of thyroid slices with TSH did not diminish TSH binding by homogenates prepared at the end of the second incubation. Furthermore, displacement of 125I-TSH from its binding sites in both homogenates was similar when 2-25 mU/ml of unlabeled TSH was added.
DISCUSSION
The present studies extend the previous observation that initial exposure of thyroid tissue to TSH induces diminished responsiveness upon subsequent addition of the hormone (1). During the refractory period, activation of protein kinase by TSH was inhibited despite a significant, but blunted, increase in cyclic AMP concentration. According to our previous results (reference 10, Table V) , even this decreased amount of cyclic AMP should have been sufficient to cause some activation of protein kinase. This might suggest that the enzyme was refractory, but this is not supported by the undiminished activation of it induced by addition of DBC to slices during the third incubation. A submaximal amount of DBC was deliberately used in case there was an alteration in sensitivity of protein kinase rather than total unresponsiveness. The results suggest that the increased cyclic AMP generated by TSH in the slices previously exposed to the hormone was not 662 I,-(I that the basis for refractoriness is more complex than unresponsiveness of adenylate cyclase. In dog thyroid slices, stimulation of glucose oxidation by TSH (7) and PGE, (15) (12, 18) . The stimulation of glucose oxidation by acetylcholine (14) was not inhibited in slices which were refractory to TSH. This observation is consistent with the involvement of the adenylate cyclase-cyclic AMP system since acetylcholine does not exert its effects via this mechanism (19) . Although the mechanism by which acetylcholine stimulates glucose oxidation is not known, the present results would indicate that it probably does not share much of a common pathway with the effect of TSH, PGE1, or DBC.
Inhibition of the TSH stimulation of 32P, incorporation into phospholipids provides further support for involvement of processes other than activation of adenylate cyclase as the cause of refractoriness. Much evidence has been provided indicating that this effect of TSH is not mediated by the adenylate cyclasecyclic AMP system (7, 20, 21 Although these studies clearly demonstrate that unresponsiveness to TSH extends to other metabolic effects of the hormone in addition to generation of cyclic AMP, they do not provide unequivocal evidence that such refractoriness is of physiological significance or involved in the hormonal regulation of thyroid gland function.
